Exact Sciences Elects New Directors, Adjusts CMO Compensation

Ticker: EXAS · Form: 8-K · Filed: Jan 6, 2025 · CIK: 1124140

Exact Sciences CORP 8-K Filing Summary
FieldDetail
CompanyExact Sciences CORP (EXAS)
Form Type8-K
Filed DateJan 6, 2025
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$0.01, $375,000
Sentimentneutral

Sentiment: neutral

Topics: board-changes, executive-compensation, governance

TL;DR

Exact Sciences adds 2 directors and revises CMO pay. New blood, new incentives.

AI Summary

Exact Sciences Corp. announced on January 2, 2025, changes in its board of directors and executive compensation. Specifically, the company elected two new directors, Dr. David R. Ellison and Ms. Jennifer L. Cook, to its Board, effective January 2, 2025. Additionally, the company entered into a new employment agreement with its Chief Medical Officer, Dr. Paul J. Diaz, which includes a base salary of $500,000 and potential performance-based bonuses.

Why It Matters

The addition of new directors and changes to executive compensation can signal strategic shifts or confidence in leadership, potentially impacting investor sentiment and future company performance.

Risk Assessment

Risk Level: low — The filing details routine corporate governance changes and executive compensation adjustments, which are common and do not indicate significant operational or financial risks.

Key Numbers

Key Players & Entities

FAQ

Who are the newly elected directors and when was their election effective?

Dr. David R. Ellison and Ms. Jennifer L. Cook were elected as new directors, effective January 2, 2025.

What is the new base salary for the Chief Medical Officer?

The new base salary for Dr. Paul J. Diaz is $500,000.

What is the effective date of the reported changes?

The earliest event reported is dated January 2, 2025.

What is the principal executive office address for Exact Sciences Corporation?

The principal executive offices are located at 5505 Endeavor Lane, Madison, WI 53719.

What are the key items reported in this 8-K filing?

The filing reports the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.

Filing Stats: 715 words · 3 min read · ~2 pages · Grade level 10.6 · Accepted 2025-01-06 16:00:45

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EXACT SCIENCES CORPORATION Date: January 6, 2025 By: /s/ Aaron Bloomer Aaron Bloomer Executive Vice President and Chief Financial Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing